Interventional Radiology for Pancreatic Cancer

  • Ferga C. Gleeson
  • Michael J. Levy
Reference work entry


Pancreatic adenocarcinoma is the tenth most common malignancy and is the fourth leading cause of cancer-related mortality and second most common cause of cancer deaths for all gastrointestinal-related carcinomas. Most patients present late in their course and have either locally extensive or metastatic disease with a median survival of only 4–6 months. At the time of diagnosis, only 10–20% of patients are candidates for curative resection. The late presentation, aggressive nature, and lack of effective therapies all contribute to the poor prognosis. It is typically in these patients with more advanced disease that interventional radiologic (IR) and endoscopic ultrasound (EUS) guided interventions are employed to provide palliative care. The objective of this chapter is to highlight currently available and emerging IR and EUS guided interventions as they apply to the care of patients with pancreatic carcinoma.


Pancreatic Cancer Intrahepatic Bile Duct Percutaneous Transhepatic Biliary Drainage Endoscopic Retrograde Cholangiography Stent Patency 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Rösch J, Dotter CT, Brown MN: Selective arterial embolization: new method for control of acute gastrointestinal bleeding. Radiology 1972;102:303–306.PubMedGoogle Scholar
  2. 2.
    Ardengh JC, Lopes CV, de Lima LF, de Oliveira JR, Venco F, Santo GC, Modena JL: Diagnosis of pancreatic tumors by endoscopic ultrasound-guided fine-needle aspiration. World J Gastroenterol 2007;13(22):3112–3116.PubMedGoogle Scholar
  3. 3.
    Bhutani MS, Hawes RH, Baron PL, Sanders-Cliette A, van Velse A, Osborne JF, Hoffman BJ: Endoscopic ultrasound guided fine needle aspiration of malignant pancreatic lesions. Endoscopy 1997;29(9):854–858.PubMedCrossRefGoogle Scholar
  4. 4.
    Chang KJ, Nguyen P, Erickson RA, Durbin TE, Katz KD: The clinical utility of endoscopic ultrasound-guided fine-needle aspiration in the diagnosis and staging of pancreatic carcinoma. Gastrointest Endosc 1997;45(5):387–393.PubMedCrossRefGoogle Scholar
  5. 5.
    Eloubeidi MA, Jhala D, Chhieng DC, Chen VK, Eltoum I, Vickers S, Mel Wilcox C, Jhala N: Yield of endoscopic ultrasound-guided fine-needle aspiration biopsy in patients with suspected pancreatic carcinoma. Cancer 2003;99(5):285–292.PubMedCrossRefGoogle Scholar
  6. 6.
    Wilson JL, Kalade A, Prasad S, Cade R, Thomson B, Banting S, Mackay S, Desmond PV, Chen RY: Diagnosis of solid pancreatic masses by endoscopic ultrasound-guided fine-needle aspiration. Intern Med J 2008;39:32–37.PubMedCrossRefGoogle Scholar
  7. 7.
    Kulesza P, Eltoum IA: Endoscopic ultrasound-guided fine-needle aspiration: sampling, pitfalls, and quality management. Clin Gastroenterol Hepatol 2007;5(11):1248–1254.PubMedCrossRefGoogle Scholar
  8. 8.
    Levy MJ, Wiersema MJ: EUS-guided Trucut biopsy. Gastrointest Endosc 2005;62(3):417–426.PubMedCrossRefGoogle Scholar
  9. 9.
    Warshaw AL, Fernandez-del Castillo C: Pancreatic carcinoma. N Engl J Med 1992;326(7):455–465.PubMedCrossRefGoogle Scholar
  10. 10.
    Smith AC, Dowsett JF, Russell RC, Hatfield AR, Cotton PB: Randomised trial of endoscopic stenting versus surgical bypass in malignant low bileduct obstruction. Lancet 1994;344(8938):1655–1660.PubMedCrossRefGoogle Scholar
  11. 11.
    Lichtenstein DR, Carr-Locke DL: Endoscopic palliation for unresectable pancreatic carcinoma. Surg Clin North Am 1995;75(5):969–988.PubMedGoogle Scholar
  12. 12.
    Leung JW, Emery R, Cotton PB, Russell RC, Vallon AG, Mason RR: Management of malignant obstructive jaundice at The Middlesex Hospital. Br J Surg 1983;70(10):584–586.PubMedCrossRefGoogle Scholar
  13. 13.
    Speer AG, Cotton PB, Russell RC, et al.: Randomised trial of endoscopic versus percutaneous stent insertion in malignant obstructive jaundice. Lancet 1987;2(8550):57–62.PubMedCrossRefGoogle Scholar
  14. 14.
    Brandabur JJ, Kozarek RA, Ball TJ, et al.: Nonoperative versus operative treatment of obstructive jaundice in pancreatic cancer: cost and survival analysis. Am J Gastroenterol 1988;83(10):1132–1139.PubMedGoogle Scholar
  15. 15.
    Shepherd HA, Royle G, Ross AP, Diba A, Arthur M, Colin-Jones D: Endoscopic biliary endoprosthesis in the palliation of malignant obstruction of the distal common bile duct: a randomized trial. Br J Surg 1988;75(12):1166–1168.PubMedCrossRefGoogle Scholar
  16. 16.
    Andersen JR, Sorensen SM, Kruse A, Rokkjaer M, Matzen P: Randomised trial of endoscopic endoprosthesis versus operative bypass in malignant obstructive jaundice. Gut 1989;30(8):1132–1135.PubMedCrossRefGoogle Scholar
  17. 17.
    van den Bosch RP, van der Schelling GP, Klinkenbijl JH, Mulder PG, van Blankenstein M, Jeekel J: Guidelines for the application of surgery and endoprostheses in the palliation of obstructive jaundice in advanced cancer of the pancreas. Ann Surg 1994;219(1):18–24.PubMedCrossRefGoogle Scholar
  18. 18.
    Mitty R, Cave DR: Randomized trial of endoscopic stenting versus surgical bypass in malignant low bile duct obstruction. Gastrointest Endosc 1995;42(3):281–282.PubMedGoogle Scholar
  19. 19.
    Raikar GV, Melin MM, Ress A, et al.: Cost-effective analysis of surgical palliation versus endoscopic stenting in the management of unresectable pancreatic cancer. Ann Surg Oncology 1996;3(5):470–475.CrossRefGoogle Scholar
  20. 20.
    Ballinger AB, McHugh M, Catnach SM, Alstead EM, Clark ML: Symptom relief and quality of life after stenting for malignant bile duct obstruction. Gut 1994;35(4):467–470.PubMedCrossRefGoogle Scholar
  21. 21.
    Luman W, Cull A, Palmer KR: Quality of life in patients stented for malignant biliary obstructions. Eur J Gastroenterol Hepatol 1997;9(5):481–484.PubMedGoogle Scholar
  22. 22.
    Abraham NS, Barkun JS, Barkun AN: Palliation of malignant biliary obstruction: a prospective trial examining impact on quality of life. Gastrointest Endosc 2002;56(6):835–841.PubMedCrossRefGoogle Scholar
  23. 23.
    Davids PH, Groen AK, Rauws EA, Tytgat GN, Huibregtse K: Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction (comment). Lancet 1992;340(8834–8835):1488–1492.PubMedCrossRefGoogle Scholar
  24. 24.
    Carr-Locke DL, Ball TJ, Connors PJ, et al.: Multicenter, randomized, controlled trial of metal stents for malignant obstruction of the common bile duct. Gastrointest Endosc 1993;39:A310.Google Scholar
  25. 25.
    Knyrim K, Wagner HJ, Pausch J, Vakil N: A prospective, randomized, controlled trial of metal stents for malignant obstruction of the common bile duct. Endoscopy 1993;25(3):207–212.PubMedCrossRefGoogle Scholar
  26. 26.
    Prat F, Chapat O, Ducot B, et al.: A randomized trial of endoscopic drainage methods for inoperable malignant strictures of the common bile duct (comment). Gastrointestinal Endoscopy 1998;47(1):1–7.PubMedCrossRefGoogle Scholar
  27. 27.
    Kaassis M, Boyer J, Dumas R, et al.: Plastic or metal stents for malignant stricture of the common bile duct? Results of a randomized prospective study. Gastrointest Endosc 2003;57:178–182.PubMedCrossRefGoogle Scholar
  28. 28.
    Schmassmann A, von Gunten E, Knuchel J, Scheurer U, Fehr HF, Halter F: Wallstents versus plastic stents in malignant biliary obstruction: effects of stent patency of the first and second stent on patient compliance and survival (comment). Am J Gastroenterol 1996;91(4):654–659.PubMedGoogle Scholar
  29. 29.
    England RE, Martin DF, Morris J, et al.: A prospective randomised multicentre trial comparing 10 Fr Teflon Tannenbaum stents with 10 Fr polyethylene Cotton-Leung stents in patients with malignant common duct strictures (comment). Gut 2000;46(3):395–400.PubMedCrossRefGoogle Scholar
  30. 30.
    Libby ED, Leung JW: Ultrasmooth plastic to prevent stent clogging (comment). Gastrointest Endosc 1994;40(3):386–387.PubMedCrossRefGoogle Scholar
  31. 31.
    Sung JY, Shaffer EA, Costerton JW: Antibacterial activity of bile salts against common biliary pathogens. Effects of hydrophobicity of the molecule and in the presence of phospholipids. Dig Dis Sci 1993;38(11):2104–2112.PubMedCrossRefGoogle Scholar
  32. 32.
    Ghosh S, Palmer KR: Prevention of biliary stent occlusion using cyclical antibiotics and ursodeoxycholic acid. Gut 1994;35(12):1757–1759.PubMedCrossRefGoogle Scholar
  33. 33.
    Levy MJ, Baron TH, Gostout CJ, Petersen BT, Farnell MB: Palliation of malignant extrahepatic biliary obstruction with plastic versus expandable metal stents: an evidence-based approach. Clin Gastroenterol Hepatol 2004;2(4):273–285.PubMedCrossRefGoogle Scholar
  34. 34.
    Takada T, Hanyu F, Kobayashi S, Uchida Y: Percutaneous transhepatic cholangial drainage: direct approach under fluoroscopic control. J Surg Oncol 1976;8:83–97.PubMedCrossRefGoogle Scholar
  35. 35.
    Saltzstein EC, Peacock JB, Mercer LC: Early operation for acute biliary tract stone disease. Surgery 1983;94:704–708.PubMedGoogle Scholar
  36. 36.
    Lameris JS, Stoker J, Nijs HG, et al.: Malignant biliary obstruction: percutaneous use of self-expandable stents. Radiology 1991;179:703–707.PubMedGoogle Scholar
  37. 37.
    Beissert M, Wittenberg G, Sandstede J, et al.: Metallic stents and plastic endoprostheses in percutaneous treatment of biliary obstruction. Z Gastroenterol 2002;40:503–510.PubMedCrossRefGoogle Scholar
  38. 38.
    Chiou YY, Tseng HS, Chiang JH, Hwang JI, Chou YH, Chang CY: Percutaneous placement of metallic stents in the management of malignant biliary obstruction. J Formos Med Assoc 2005;104(10):738–743.PubMedGoogle Scholar
  39. 39.
    Mallery S, Matlock J, Freeman M: EUS-guided rendezvous drainage of obstructed biliary and pancreatic ducts: report of 6 cases. Gastrointest Endosc. 2004;59(1):100–107.PubMedCrossRefGoogle Scholar
  40. 40.
    Bories E, Pesenti C, Caillol F, Lopes C, Giovannini M: Transgastric endoscopic ultrasonography-guided biliary drainage: results of a pilot study. Endoscopy 2007;39(4):287–291.PubMedCrossRefGoogle Scholar
  41. 41.
    Wiersema MJ, Sandusky D, Carr R, Wiersema LM, Erdel WC, Frederick PK: Endosonography-guided cholangiopancreatography. Gastrointest Endosc 1996;43(2 Pt 1):102–106.PubMedCrossRefGoogle Scholar
  42. 42.
    Giovannini M, Moutardier V, Presenti C, et al.: Endoscopic ultrasound-guided bilioduodenal anastomosis: a new technique for biliary drainage. Endoscopy 2001;33(10):898–900.PubMedCrossRefGoogle Scholar
  43. 43.
    Burmester E, Niehaus J, Leineweber T, et al.: EUS-cholangiodrainage of the bile duct: report of 4 cases. Gastrointest Endosc 2003;57(2):246–250.PubMedCrossRefGoogle Scholar
  44. 44.
    Kahaleh M, Yoshida C, Kane L, Yeaton P: Interventional EUS cholangiography: a report of five cases. Gastrointest Endosc 2004;60:138–142.PubMedCrossRefGoogle Scholar
  45. 45.
    Lai R, Freeman ML: Endoscopic ultrasound-guided bile duct access for rendezvous ERCP drainage in the setting of intradiverticular papilla. Endoscopy 2005;37(5):487–489.PubMedCrossRefGoogle Scholar
  46. 46.
    Puspok A, Lomoschitz F, Dejaco C, et al.: Endoscopic ultrasound guided therapy of benign and malignant biliary obstruction: a case series. Am J Gastroenterol 2005;100:1743–1747.PubMedCrossRefGoogle Scholar
  47. 47.
    Kahaleh M, Hernandez AJ, Tokar J, Adams RB, Shami VM, Yeaton P: Interventional EUS-guided cholangiography: evaluation of a technique in evolution. Gastrointest Endosc 2006;64(1):52–59.PubMedCrossRefGoogle Scholar
  48. 48.
    Yamao K, Sawaki A, Takahashi K, Imaoka H, Ashida R, Mizuno N: EUS-guided choledochoduodenostomy for palliative biliary drainage in case of papillary obstruction: report of 2 cases. Gastrointest Endosc 2006;64(4):663–667.PubMedCrossRefGoogle Scholar
  49. 49.
    Will U, Thieme A, Fueldner F, Gerlach R, Wanzar I, Meyer F: Treatment of biliary obstruction in selected patients by endoscopic ultrasonography (EUS)-guided transluminal biliary drainage. Endoscopy 2007;39(4):292–295.PubMedCrossRefGoogle Scholar
  50. 50.
    Ang TL, Teo EK, Fock KM: EUS-guided transduodenal biliary drainage in unresectable pancreatic cancer with obstructive jaundice. JOP 2007;8(4):438–443.PubMedGoogle Scholar
  51. 51.
    Fuji N, Noda Y, Kobayashi G, Ito K, Obana T, Horaguchi J, Takasawa O, Nakahara K.: Histological changes at an endosonography-guided biliary drainage site: a case report. World J Gastroenterol 2007;13(41):5512–5515.Google Scholar
  52. 52.
    Yamao K, Bhatia V, Mizuno N, Sawaki A, Ishikawa H, Tajika M, Hoki N, Shimizu Y, Ashida R, Fukami N: EUS-guided choledochoduodenostomy for palliative biliary drainage in patients with malignant biliary obstruction: results of long-term follow-up. Endoscopy 2008;40(4):340–342.PubMedCrossRefGoogle Scholar
  53. 53.
    Tarantino I, Barresi L, Repici A, Traina M. EUS-guided biliary drainage: a case series. Endoscopy 2008;40(4):336–339.Google Scholar
  54. 54.
    Adler DG, Baron TH: Endoscopic palliation of malignant gastric outlet obstruction using self-expanding metal stents: experience in 36 patients. Am J Gastroenterol 2002;97(1):72–78.PubMedCrossRefGoogle Scholar
  55. 55.
    Dormann A, Meisner S, Verin N, Wenk Lang A: Self-expanding metal stents for gastroduodenal malignancies: systematic review of their clinical effectiveness. Endoscopy 2004;36(6):543–550.PubMedCrossRefGoogle Scholar
  56. 56.
    Graber I, Dumas R, Filoche B, Boyer J, Coumaros D, Lamouliatte H, Legoux JL, Napoléon B, Ponchon T, Société Française d'Endoscopie Digestive (SFED). The efficacy and safety of duodenal stenting: a prospective multicenter study. Endoscopy 2007;39(9):784–787.PubMedCrossRefGoogle Scholar
  57. 57.
    Mutignani M, Tringali A, Shah SG, Perri V, Familiari P, Iacopini F, Spada C, Costamagna G: Combined endoscopic stent insertion in malignant biliary and duodenal obstruction. Endoscopy 2007;39(5):440–447.PubMedCrossRefGoogle Scholar
  58. 58.
    Ventafridda GV, Caraceni AT, Sbanotto AM, Barletta L, De Conno F: Pain treatment in cancer of the pancreas. Eur J Surg Oncol 1990;16(1):1–6.PubMedGoogle Scholar
  59. 59.
    Lankisch PG: Natural course of chronic pancreatitis. Pancreatology 2001;1(1):3–14.PubMedCrossRefGoogle Scholar
  60. 60.
    Ventafridda V, Tamburini M, Caraceni A, De Conno F, Naldi F: A validation study of the WHO method for cancer pain relief. Cancer 1987;59(4):850–856.PubMedCrossRefGoogle Scholar
  61. 61.
    Yeager MP, Colacchio TA, Yu CT, et al.: Morphine inhibits spontaneous and cytokine-enhanced natural killer cell cytotoxicity in volunteers. Anesthesiology 1995;83(3):500–508.PubMedCrossRefGoogle Scholar
  62. 62.
    Ward EM, Rorie DK, Nauss LA, Bahn RC: The celiac ganglia in man: normal anatomic variations. Anesth Analg 1979;58(6):461–465.PubMedCrossRefGoogle Scholar
  63. 63.
    Ischia S, Ischia A, Polati E, Finco G: Three posterior percutaneous celiac plexus block techniques. A prospective, randomized study in 61 patients with pancreatic cancer pain. Anesthesiology 1992;76(4):534–540.PubMedCrossRefGoogle Scholar
  64. 64.
    Brown DL, Moore DC: The use of neurolytic celiac plexus block for pancreatic cancer: anatomy and technique. J Pain Symptom Manage 1988;3(4):206–209.PubMedCrossRefGoogle Scholar
  65. 65.
    Plancarte R, Velasquez R, Patt R: Neurolytic blocks of the sympathetic axis. In: Cancer Pain. Patt RB (ed.). Philadelphia, PA: Lippincott;1993:377–425.Google Scholar
  66. 66.
    Nagakawa T, Mori K, Nakano T, et al.: Perineural invasion of carcinoma of the pancreas and biliary tract. British Journal of Surgery 1993;80(5):619–621.PubMedCrossRefGoogle Scholar
  67. 67.
    Gebhardt GF: Visceral pain mechanisms. In: Chapman CR, Foley KM (eds.). Current and emerging issues in cancer pain. New York: Raven Press;1993:99–111.Google Scholar
  68. 68.
    Kappis M: Erfahrungen mit local anasthesie bie bauchoperationen. Vehr Dtsch Gesellsch Chir 1914;43:87–89.Google Scholar
  69. 69.
    Mercadante S, Nicosia F: Celiac plexus block: a reappraisal (comment). Reg Anesth Pain Med 1998;23(1):37–48.PubMedGoogle Scholar
  70. 70.
    Lebovits AH, Lefkowitz M: Pain management of pancreatic carcinoma: a review. Pain 1989;36(1):1–11.PubMedCrossRefGoogle Scholar
  71. 71.
    Sharfman WH, Walsh TD: Has the analgesic efficacy of neurolytic celiac plexus block been demonstrated in pancreatic cancer pain? Pain 1990;41(3):267–271.PubMedCrossRefGoogle Scholar
  72. 72.
    Eisenberg E, Carr DB, Chalmers TC: Neurolytic celiac plexus block for treatment of cancer pain: a meta-analysis (erratum appears in Anesth Analg 1995 Jul;(81)1:213). Anesth Analg 1995;80(2):290–295.PubMedCrossRefGoogle Scholar
  73. 73.
    Polati E, Finco G, Gottin L, Bassi C, Pederzoli P, Ischia S: Prospective randomized double-blind trial of neurolytic coeliac plexus block in patients with pancreatic cancer. Br J Surg 1998;85(2):199–201.PubMedCrossRefGoogle Scholar
  74. 74.
    Kawamata M, Ishitani K, Ishikawa K, et al.: Comparison between celiac plexus block and morphine treatment on quality of life in patients with pancreatic cancer pain. Pain 1996;64(3):597–602.PubMedCrossRefGoogle Scholar
  75. 75.
    Wong GY, Schroeder DR, Carns PE, Wilson JL, Martin DP, Kinney MO, Mantilla CB, Warner DO: Effect of neurolytic celiac plexus block on pain relief, quality of life, and survival in patients with unresectable pancreatic cancer: a randomized controlled trial. JAMA 2004;291(9):1092–1099.PubMedCrossRefGoogle Scholar
  76. 76.
    Davies DD: Incidence of major complications of neurolytic coeliac plexus block. J R Soc Med 1993;86(5):264–266.PubMedGoogle Scholar
  77. 77.
    De Conno F, Caraceni A, Aldrighetti L, et al.: Paraplegia following coeliac plexus block (comment). Pain 1993;55(3):383–385.PubMedCrossRefGoogle Scholar
  78. 78.
    van Dongen RT, Crul BJ: Paraplegia following coeliac plexus block. Anaesthesia 1991;46(10):862–863.PubMedCrossRefGoogle Scholar
  79. 79.
    Hayakawa J, Kobayashi O, Murayama H: Paraplegia after intraoperative celiac plexus block. Anesth Analg 1997;84(2):447–448.PubMedCrossRefGoogle Scholar
  80. 80.
    Wiersema MJ, Wiersema LM: Endosonography-guided celiac plexus neurolysis. Gastrointest Endosc 1996;44(6):656–662.PubMedCrossRefGoogle Scholar
  81. 81.
    Gunaratnam NT, Sarma AV, Norton ID, Wiersema MJ: A prospective study of EUS-guided celiac plexus neurolysis for pancreatic cancer pain. Gastrointest Endosc 2001;54(3):316–324.PubMedCrossRefGoogle Scholar
  82. 82.
    Levy MJ, Wiersema MJ: EUS-guided celiac plexus neurolysis and celiac plexus block. Gastrointest Endosc 2003;57(7):923–930.PubMedCrossRefGoogle Scholar
  83. 83.
    Levy MJ, Topazian MD, Wiersema MJ, Clain JE, Rajan E, Wang KK, de la Mora JG, Gleeson FC, Pearson RK, Pelaez MC, Petersen BT, Vege SS, Chari ST: Initial evaluation of the efficacy and safety of endoscopic ultrasound-guided direct Ganglia neurolysis and block. Am J Gastroenterol 2008;103(1):98–103.PubMedGoogle Scholar
  84. 84.
    Moertel CG, Childs DS, Jr., Reitemeier RJ, Colby MY, Jr., Holbrook MA: Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer. Lancet 1969;2(7626):865–867.PubMedCrossRefGoogle Scholar
  85. 85.
    Burris HA, 3rd, Moore MJ, Andersen J, et al.: Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial (see comment). J Clin Oncol 1997;15(6):2403–2413.PubMedGoogle Scholar
  86. 86.
    Li CP, Chao Y, Chi KH, et al.: Concurrent chemoradiotherapy treatment of locally advanced pancreatic cancer: gemcitabine versus 5-fluorouracil, a randomized controlled study (see comment). Int J Radiat Oncol Biol Phys 2003;57(1):98–104.PubMedCrossRefGoogle Scholar
  87. 87.
    Heinemann V, Hertel LW, Grindey GB, Plunkett W: Comparison of the cellular pharmacokinetics and toxicity of 2′,2′-difluorodeoxycytidine and 1-beta-D-arabinofuranosylcytosine.  Cancer Res 1988;48(14):4024–4031.PubMedGoogle Scholar
  88. 88.
    van Moorsel CJ, Bergman AM, Veerman G, et al.: Differential effects of gemcitabine on ribonucleotide pools of twenty-one solid tumour and leukaemia cell lines. Biochimica et Biophysica Acta 2000;1474(1):5–12.PubMedGoogle Scholar
  89. 89.
    Huang P, Plunkett W: Fludarabine- and gemcitabine-induced apoptosis: incorporation of analogs into DNA is a critical event. Cancer Chemother Pharmacol 1995;36(3):181–188.PubMedCrossRefGoogle Scholar
  90. 90.
    Ujiki MB, Talamonti MS: Guidelines for the surgical management of pancreatic adenocarcinoma. Semin Oncol 2007;34(4):311–320.PubMedCrossRefGoogle Scholar
  91. 91.
    Tanaka T, Sakaguchi H, Anai H, Yamamoto K, Morimoto K, Tamamoto T, Kichikawa K: Arterial infusion of 5-fluorouracil combined with concurrent radiotherapy for unresectable pancreatic cancer: results from a pilot study. AJR Am J Roentgenol 2007;189(2):421–428.PubMedCrossRefGoogle Scholar
  92. 92.
    Takamori H, Kanemitsu K, Tsuji T, Tanaka H, Chikamoto A, Nakahara O, Hiraoka T, Ikeda O, Kudo K, Imuta M, Yamashita Y: 5-fluorouracil intra-arterial infusion combined with systemic gemcitabine for unresectable pancreatic cancer. Pancreas 2005;30(3):223–226.PubMedCrossRefGoogle Scholar
  93. 93.
    Miyanishi K, Ishiwatari H, Hayashi T, Takahashi M, Kawano Y, Takada K, Ihara H, Okuda T, Takanashi K, Takahashi S, Sato Y, Matsunaga T, Homma H, Kato J, Niitsu Y: A Phase I trial of arterial infusion chemotherapy with gemcitabine and 5-fluorouracil for unresectable advanced pancreatic cancer after vascular supply distribution via superselective embolization. Jpn J Clin Oncol 2008;38(4):268–274.PubMedCrossRefGoogle Scholar
  94. 94.
    Sasada T, Denno R, Tanaka T, Kanai M, Mizukami Y, Kohno S, Takabayashi A: Intra-arterial infusion chemotherapy with 5-fluorouracil and cisplatin in advanced pancreatic cancer: a feasibility study. Am J Clin Oncol 2008;31(1):71–78.PubMedCrossRefGoogle Scholar
  95. 95.
    Mambrini A, Bassi C, Pacetti P, Torri T, Iacono C, Ballardini M, Orlandi M, Guadagni S, Fiorentini G, Cantore M: Prognostic factors in patients with advanced pancreatic adenocarcinoma treated with intra-arterial chemotherapy. Pancreas 2008;36(1):56–60.PubMedCrossRefGoogle Scholar
  96. 96.
    Furuse J, Maru Y, Yoshino M, Mera K, Sumi H, Tajiri H, Satake M, Onaya H, Ishikura S, Ogino T, Kawashima M, Ikeda H: Hepatic arterial infusion of 5-fluorouracil for liver metastases from pancreatic carcinoma: results from a pilot study. Hepatogastroenterology 2001;48(37):208–211.PubMedGoogle Scholar
  97. 97.
    Ishii H, Furuse J, Nagase M, Yoshino M, Kawashima M, Satake M, Ogino T, Ikeda H: Hepatic arterial infusion of 5-fluorouracil and extrabeam radiotherapy for liver metastases from pancreatic carcinoma. Hepatogastroenterology 2004;51(58):1175–1178.PubMedGoogle Scholar
  98. 98.
    Mulvihill S, Warren R, Venook A, et al.: Safety and feasibility of injection with an E1B-55 kDa gene-deleted, replication-selective adenovirus (ONYX-015) into primary carcinomas of the pancreas: a phase I trial. Gene Ther 2001;8(4):308–315.PubMedCrossRefGoogle Scholar
  99. 99.
    Micames C, Jowell PS, White R, et al.: Lower frequency of peritoneal carcinomatosis in patients with pancreatic cancer diagnosed by EUS-guided FNA vs. percutaneous FNA. Gastrointest Endosc 2003;58(5):690–695.PubMedCrossRefGoogle Scholar
  100. 100.
    Vilmann P, Jacobsen GK, Henriksen FW, Hancke S: Endoscopic ultrasonography with guided fine needle aspiration biopsy in pancreatic disease. Gastrointest Endosc 1992;38(2):172–173.PubMedCrossRefGoogle Scholar
  101. 101.
    Erickson RA: EUS-guided FNA. Gastrointest Endosc 2004;60(2):267–279.PubMedCrossRefGoogle Scholar
  102. 102.
    Chang KJ, Nguyen PT, Thompson JA, et al.: Phase I clinical trial of allogeneic mixed lymphocyte culture (cytoimplant) delivered by endoscopic ultrasound-guided fine-needle injection in patients with advanced pancreatic carcinoma. Cancer 2000;88(6):1325–1335.PubMedCrossRefGoogle Scholar
  103. 103.
    Hecht JR, et al.: A phase I/II trial of intratumoral endoscopic ultrasound injection of ONYX-015 with intravenous gemcitabine in unresectable pancreatic carcinoma. Clin Cancer Res 2003;9:555–561.PubMedGoogle Scholar
  104. 104.
    Chang KJ, et al.: A novel gene transfer therapy against pancreatic cancer (TNFerade) delivered by endoscopic ultrasound (EUS) and percutaneous guided fine needle injection (FNI) (abstract). Gastrointest Endosc 2004;59:188.Google Scholar
  105. 105.
    Chang KJ, et al.: Multi-center clinical trial using endoscopy and endoscopic ultrasound (EUS) guided fine needle injection (FNI) of anti-tumor agent (TNFerade™) in patients with locally advanced esophageal cancer (abstract). Gastrointest Endosc 2006;63:AB83.CrossRefGoogle Scholar
  106. 106.
    Farrell JJ, et al.: Long-term data for endoscopic ultrasound (EUS) and percutaneous (PTA) guided intratumoral TNFerade gene delivery combined with chemoradiation in the treatment of locally advanced pancreatic cancer (LAPC) (abstract). Gastrointest Endosc 2006;63:AB93.CrossRefGoogle Scholar
  107. 107.
    Jeong B, Bae YH, Lee DS, Kim SW: Biodegradable block copolymers as injectable drug-delivery systems. Nature 1997;388(6645):860–862.PubMedCrossRefGoogle Scholar
  108. 108.
    Linghu E, Matthes K, Mino-Kenudson M, Brugge WR: Feasibility of endoscopic ultrasound-guided OncoGel (ReGel/paclitaxel) injection into the pancreas in pigs. Endoscopy 2005;37(11):1140–1142.PubMedCrossRefGoogle Scholar
  109. 109.
    Matthes K, Mino-Kenudson M, Sahani DV, Holalkere N, Fowers KD, Rathi R, Brugge WR: EUS-guided injection of paclitaxel (OncoGel) provides therapeutic drug concentrations in the porcine pancreas (with video). Gastrointest Endosc 2007;65(3):448–453.PubMedCrossRefGoogle Scholar
  110. 110.
    Sun S, Wang S, Ge N, Lei T, Lu Q, Zhou Z, Yang A, Wang Z, Sun M: Endoscopic ultrasound-guided interstitial chemotherapy in the pancreas: results in a canine model. Endoscopy 2007;39(6):530–534.PubMedCrossRefGoogle Scholar
  111. 111.
    Irisawa A, Takagi T, Kanazawa M, et al.: Endoscopic ultrasound-guided fine-needle injection of immature dendritic cells into advanced pancreatic cancer refractory to gemcitabine: a pilot study. Pancreas 2007;35(2):189–190.PubMedCrossRefGoogle Scholar
  112. 112.
    Grado GL, Larson TR, Balch CS, Grado MM, Collins JM, Kriegshauser JS, Swanson GP, Navickis RJ, Wilkes MM: Actuarial disease-free survival after prostate cancer brachytherapy using interactive techniques with biplane ultrasound and fluoroscopic guidance. Int J Radiat Oncol Biol Phys 1998;42(2):289–298.PubMedCrossRefGoogle Scholar
  113. 113.
    Xue J, Waterman F, Handler J, Gressen E: The effect of interobserver variability on transrectal ultrasonography-based postimplant dosimetry. Brachytherapy 2006;5(3):174–182.PubMedCrossRefGoogle Scholar
  114. 114.
    Firusian N, Dempke W: An early phase II study of intratumoral P-32 chromic phosphate injection therapy for patients with refractory solid tumors and solitary metastases. Cancer 1999;85(4):980–987.PubMedCrossRefGoogle Scholar
  115. 115.
    Order SE, Siegel JA, Principato R, et al.: Selective tumor irradiation by infusional brachytherapy in nonresectable pancreatic cancer: a phase I study. Int J Radiat Oncol Biol Phys 1996;36(5):1117–1126.PubMedCrossRefGoogle Scholar
  116. 116.
    Rosemurgy A, Luzardo G, Cooper J, et al.: 32P as an adjunct to standard therapy for locally advanced unresectable pancreatic cancer: a randomized trial. J Gastrointest Surg 2008;12(4):682–688.PubMedCrossRefGoogle Scholar
  117. 117.
    Peretz T, Nori D, Hilaris B, Manolatos S, Linares L, Harrison L, Anderson LL, Fuks Z, Brennan MF: Treatment of primary unresectable carcinoma of the pancreas with I-125 implantation. Int J Radiat Oncol Biol Phys 1989;17(5):931–935.PubMedCrossRefGoogle Scholar
  118. 118.
    Joyce F, Burcharth F, Holm HH, Strøyer I: Ultrasonically guided percutaneous implantation of iodine-125 seeds in pancreatic carcinoma. Int J Radiat Oncol Biol Phys 1990;19(4):1049–1052.PubMedCrossRefGoogle Scholar
  119. 119.
    Zhang FJ, Wu PH, Zhao M, Huang JH, Fan WJ, Gu YK, Liu J, Zhang L, Lu MJ: CT guided radioactive seed 125I implantation in treatment of pancreatic cancer Zhonghua Yi Xue Za Zhi 2006;86(4):223–227.PubMedGoogle Scholar
  120. 120.
    Xu KC, Niu LZ, Hu YZ, He WB, He YS, Li YF, Zuo JS: A pilot study on combination of cryosurgery and (125)iodine seed implantation for treatment of locally advanced pancreatic cancer. World J Gastroenterol 2008;14(10):1603–1611.PubMedCrossRefGoogle Scholar
  121. 121.
    Dobelbower RR, Montemaggi P: Brachytherapy for pancreatic cancer: a review. Hepato Gastroenterology 1996;43:333–337.PubMedGoogle Scholar
  122. 122.
    Shirato H, Harada T, Harabayashi T, Hida K, Endo H, Kitamura K, Onimaru R, Yamazaki K, Kurauchi N, Shimizu T, Shinohara N, Matsushita M, Dosaka-Akita H, Miyasaka K: Feasibility of insertion/implantation of 2.0-mm-diameter gold internal fiducial markers for precise setup and real-time tumor tracking in radiotherapy. Int J Radiat Oncol Biol Phys 2003;56(1):240–247.PubMedCrossRefGoogle Scholar
  123. 123.
    Murphy MJ, Adler JR Jr., Bodduluri M, Dooley J, Forster K, Hai J, Le Q, Luxton G, Martin D, Poen J: Image-guided radiosurgery for the spine and pancreas. Comput Aided Surg 2000;5(4):278–288.PubMedCrossRefGoogle Scholar
  124. 124.
    Pishvaian AC, Collins B, Gagnon G, Ahlawat S, Haddad NG: EUS-guided fiducial placement for CyberKnife radiotherapy of mediastinal and abdominal malignancies. Gastrointest Endosc 2006;64(3):412–417.PubMedCrossRefGoogle Scholar
  125. 125.
    Yan BM, Schellenberg D, Kim J, et al.: EUS-guided gold fiducial insertion for image-guided radiation therapy of pancreatic cancer. Gastrointest Endosc 2008;67:AB225.CrossRefGoogle Scholar
  126. 126.
    Sun S, Qingjie L, Qiyong G, Mengchun W, Bo Q, Hong X: EUS-guided interstitial brachytherapy of the pancreas: a feasibility study. Gastrointest Endosc 2005;62(5):775–779.PubMedCrossRefGoogle Scholar
  127. 127.
    Sun S, Xu H, Xin J, Liu J, Guo Q, Li S: Endoscopic ultrasound-guided interstitial brachytherapy of unresectable pancreatic cancer: results of a pilot trial. Endoscopy 2006;38(4):399–403.PubMedCrossRefGoogle Scholar
  128. 128.
    Jin Z, Du Y, Li Z, Jiang Y, Chen J, Liu Y: Endoscopic ultrasonography-guided interstitial implantation of iodine 125-seeds combined with chemotherapy in the treatment of unresectable pancreatic carcinoma: a prospective pilot study. Endoscopy 2008;40(4):314–320.PubMedCrossRefGoogle Scholar
  129. 129.
    Wilson BC: Photodynamic therapy for cancer principles. Can J Gastroenterol 2002;16:393–396.PubMedGoogle Scholar
  130. 130.
    Moesta KT, Schlag P, Douglass HO Jr., et al.: Evaluating the role of photodynamic therapy in the management of pancreatic cancer. Lasers Surg Med 1995;16:84–92.PubMedCrossRefGoogle Scholar
  131. 131.
    Fan BG, Andrén-Sandberg A: Photodynamic therapy for pancreatic cancer. Pancreas 2007;34(4):385–389.PubMedCrossRefGoogle Scholar
  132. 132.
    Bown SG, Rogowska AZ, Whitelaw DE, Lees WR, Lovat LB, Ripley P, Jones L, Wyld P, Gillams A, Hatfield AW: Photodynamic therapy for cancer of the pancreas. Gut 2002;50(4):549–557.PubMedCrossRefGoogle Scholar
  133. 133.
    Regula J, Ravi B, Bedwell J, et al.: Photodynamic therapy using 5-aminolevulinic acid for experimental pancreatic cancer prolonged animal survival. Br J Cancer 1994;70:248–254.PubMedGoogle Scholar
  134. 134.
    Chan HH, Nishioka NS, Mino M, Lauwers GY, Puricelli WP, Collier KN, Brugge WR: EUS-guided photodynamic therapy of the pancreas: a pilot study. Gastrointest Endosc 2004;59(1):95–99.PubMedCrossRefGoogle Scholar
  135. 135.
    Yusuf TE, Matthes K, Brugge WR: EUS-guided photodynamic therapy with verteporfin for ablation of normal pancreatic tissue: a pilot study in a porcine model (with video). Gastrointest Endosc 2008;67(6):957–961.PubMedCrossRefGoogle Scholar
  136. 136.
    Tang Z, Wu YL, Fang HQ, Xu J, Mo GQ, Chen XM, Gao SL, Li JT, Liu YB, Wang Y: Treatment of unresectable pancreatic carcinoma by radiofrequency ablation with “cool-tip needle”: report of 18 cases. Zhonghua Yi Xue Za Zhi 2008;88(6):391–394.PubMedGoogle Scholar
  137. 137.
    Spiliotis JD, Datsis AC, Michalopoulos NV, Kekelos SP, Vaxevanidou A, Rogdakis AG, Christopoulou AN: Radiofrequency ablation combined with palliative surgery may prolong survival of patients with advanced cancer of the pancreas. Langenbecks Arch Surg 2007;392(1):55–60.PubMedCrossRefGoogle Scholar
  138. 138.
    Varshney S, Sewkani A, Sharma S, Kapoor S, Naik S, Sharma A, Patel K: Radiofrequency ablation of unresectable pancreatic carcinoma: feasibility, efficacy and safety. JOP 2006;7(1):74–78.PubMedGoogle Scholar
  139. 139.
    Carrafiello G, Laganà D, Recaldini C, Dionigi G, Boni L, Bacuzzi A, Fugazzola C: Radiofrequency ablation of a pancreatic metastasis from renal cell carcinoma: case report. Surg Laparosc Endosc Percutan Tech 2008;18(1):64–66.PubMedCrossRefGoogle Scholar
  140. 140.
    Carrafiello G, Laganà D, Ianniello A, Dionigi G, Novario R, Recaldini C, Mangini M, Cuffari S, Fugazzola C: Post-radiofrequency ablation syndrome after percutaneous radiofrequency of abdominal tumours: one centre experience and review of published works. Australas Radiol 2007;51(6):550–554.PubMedCrossRefGoogle Scholar
  141. 141.
    Date RS, McMahon RF, Siriwardena AK: Radiofrequency ablation of the pancreas. I: Definition of optimal thermal kinetic parameters and the effect of simulated portal venous circulation in an ex-vivo porcine model. JOP 2005;6(6):581–587.PubMedGoogle Scholar
  142. 142.
    Ng KK, Lam CM, Poon RT, Shek TW, Fan ST, Wong J: Delayed portal vein thrombosis after experimental radiofrequency ablation near the main portal vein. Br J Surg 2004;91(5):632–639.PubMedCrossRefGoogle Scholar
  143. 143.
    Wu Y, Tang Z, Fang H, Gao S, Chen J, Wang Y, Yan H: High operative risk of cool-tip radiofrequency ablation for unresectable pancreatic head cancer. J Surg Oncol 2006;94(5):392–395.PubMedCrossRefGoogle Scholar
  144. 144.
    Goldberg SN, Mallery S, Gazelle GS, Brugge WR: EUS-guided radiofrequency ablation in the pancreas: results in a porcine model. Gastrointest Endosc 1999;50(3):392–401.PubMedCrossRefGoogle Scholar
  145. 145.
    Hines-Peralta A, Hollander CY, Solazzo S, Horkan C, Liu ZJ, Goldberg SN: Hybrid radiofrequency and cryoablation device: preliminary results in an animal model. J Vasc Interv Radiol 2004;15(10):1111–1120.PubMedGoogle Scholar
  146. 146.
    Carrara S, Arcidiacono PG, Albarello L, Addis A, Enderle MD, Boemo C, Campagnol M, Ambrosi A, Doglioni C, Testoni PA: Endoscopic ultrasound-guided application of a new hybrid cryotherm probe in porcine pancreas: a preliminary study. Endoscopy 2008;40(4):321–326.PubMedCrossRefGoogle Scholar
  147. 147.
    Giorgio A, Tarantino L, de Stefano G, Perrotta A, Aloisio V, del Viscovo L, Alaia A, Lettieri G: Ultrasound-guided percutaneous ethanol injection under general anesthesia for the treatment of hepatocellular carcinoma on cirrhosis: long-term results in 268 patients. Eur J Ultrasound 2000;12(2):145–154.PubMedCrossRefGoogle Scholar
  148. 148.
    Barclay RL, Perez-Miranda M, Giovannini M: EUS-guided treatment of a solid hepatic metastasis. Gastrointest Endosc 2002;55(2):266–270.PubMedCrossRefGoogle Scholar
  149. 149.
    Artifon EL, Lucon AM, Sakai P, Gerhardt R, Srougi M, Takagaki T, Ishioka S, Bhutani MS: EUS-guided alcohol ablation of left adrenal metastasis from non-small-cell lung carcinoma. Gastrointest Endosc 2007;66(6):1201–1205.PubMedCrossRefGoogle Scholar
  150. 150.
    Günter E, Lingenfelser T, Eitelbach F, Müller H, Ell C: EUS-guided ethanol injection for treatment of a GI stromal tumor. Gastrointest Endosc 2003;57(1):113–115.PubMedCrossRefGoogle Scholar
  151. 151.
    Aslanian H, Salem RR, Marginean C, Robert M, Lee JH, Topazian M: EUS-guided ethanol injection of normal porcine pancreas: a pilot study. Gastrointest Endosc 2005;62(5):723–727.PubMedCrossRefGoogle Scholar
  152. 152.
    Matthes K, Mino-Kenudson M, Sahani DV, Holalkere N, Brugge WR: Concentration-dependent ablation of pancreatic tissue by EUS-guided ethanol injection. Gastrointest Endosc 2007;65(2):272–277.PubMedCrossRefGoogle Scholar
  153. 153.
    Giday SA, Magno P, Gabrielson KL, et al.: The utility of contrast-enhanced endoscopic ultrasound in monitoring ethanol-induced pancreatic tissue ablation: a pilot study in a porcine model. Endoscopy 2007;39(6):525–529.PubMedCrossRefGoogle Scholar
  154. 154.
    Jürgensen C, Schuppan D, Neser F, Ernstberger J, Junghans U, Stölzel U: EUS-guided alcohol ablation of an insulinoma. Gastrointest Endosc 2006;63(7):1059–1062.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Ferga C. Gleeson
    • 1
  • Michael J. Levy
    • 1
  1. 1.Division of Gastroenterology and HepatologyMayo Clinic College of MedicineRochesterUSA

Personalised recommendations